Drug-induced phospholipidosis

FEBS Lett. 2006 Oct 9;580(23):5533-40. doi: 10.1016/j.febslet.2006.08.061. Epub 2006 Sep 5.


Drug-induced phospholipidosis is characterized by intracellular accumulation of phospholipids with lamellar bodies, most likely from an impaired phospholipid metabolism of the lysosome. Organs affected by phospholipidosis exhibit inflammatory reactions and histopathological changes. Despite significant advances in the understanding of drug-altered lipid metabolism, the relationship between impaired phospholipid metabolism and drug-induced toxicity remains enigmatic. Here we review molecular features of inheritable lysosomal storage disorders as a molecular mimicry of drug-induced phospholipidosis for an improved understanding of adverse drug reaction.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Lipidoses / chemically induced*
  • Lipidoses / metabolism
  • Lipidoses / pathology*
  • Lysosomes / metabolism
  • Phospholipids / metabolism*


  • Phospholipids